======= QARS ======= == Gene Information == * **Official Symbol**: QARS1 * **Official Name**: glutaminyl-tRNA synthetase 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=5859|5859]] * **UniProt**: [[https://www.uniprot.org/uniprot/P47897|P47897]] * **Interactions**: [[https://thebiogrid.org/search.php?search=QARS&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20QARS|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603727|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Glutamine--tRNA ligase (PubMed:26869582). Plays a critical role in brain development (PubMed:24656866). {ECO:0000269|PubMed:24656866, ECO:0000269|PubMed:26869582}. |tRNA synt 1c R2| |tRNA-synt 1c C| |tRNA-synt 1c| |tRNA synt 1c R1| |glutaminyl-tRNA aminoacylation| |glutamine-tRNA ligase activity| |aminoacyl-tRNA synthetase multienzyme complex| |protein kinase inhibitor activity| |negative regulation of stress-activated MAPK cascade| |tRNA aminoacylation for protein translation| |negative regulation of stress-activated protein kinase signaling cascade| |tRNA aminoacylation| |amino acid activation| |negative regulation of MAPK cascade| |tRNA metabolic process| |negative regulation of protein kinase activity| |negative regulation of apoptotic signaling pathway| |regulation of stress-activated MAPK cascade| |regulation of stress-activated protein kinase signaling cascade| |negative regulation of kinase activity| |negative regulation of transferase activity| |cellular amino acid metabolic process| |mitochondrial matrix| |translation| |regulation of apoptotic signaling pathway| |negative regulation of protein phosphorylation| |peptide biosynthetic process| |negative regulation of phosphorylation| |protein kinase binding| |ncRNA metabolic process| |negative regulation of intracellular signal transduction| |amide biosynthetic process| |peptide metabolic process| |negative regulation of phosphate metabolic process| |negative regulation of phosphorus metabolic process| |negative regulation of protein modification process| |protein-containing complex| |regulation of cellular response to stress| |brain development| |regulation of MAPK cascade| |head development| |cellular amide metabolic process| |negative regulation of catalytic activity| |regulation of protein kinase activity| |regulation of kinase activity| |negative regulation of apoptotic process| |negative regulation of programmed cell death| |carboxylic acid metabolic process| |regulation of transferase activity| |central nervous system development| |negative regulation of cell death| |oxoacid metabolic process| |organic acid metabolic process| |negative regulation of cellular protein metabolic process| |negative regulation of protein metabolic process| |negative regulation of molecular function| |negative regulation of transcription, DNA-templated| |negative regulation of nucleic acid-templated transcription| |negative regulation of RNA biosynthetic process| |negative regulation of signal transduction| |negative regulation of RNA metabolic process| |negative regulation of cell communication| |negative regulation of signaling| |negative regulation of cellular macromolecule biosynthetic process| |organonitrogen compound biosynthetic process| |negative regulation of nucleobase-containing compound metabolic process| |regulation of protein phosphorylation| |negative regulation of macromolecule biosynthetic process| |regulation of response to stress| |ATP binding| |negative regulation of cellular biosynthetic process| |regulation of apoptotic process| |negative regulation of biosynthetic process| |regulation of programmed cell death| |regulation of phosphorylation| |negative regulation of response to stimulus| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |regulation of cell death| |cellular macromolecule biosynthetic process| |negative regulation of gene expression| |small molecule metabolic process| |macromolecule biosynthetic process| |regulation of phosphate metabolic process| |regulation of phosphorus metabolic process| |regulation of intracellular signal transduction| |regulation of protein modification process| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp89|Vemurafenib 6.6μM R02 exp89]]|-3.64| |[[:results:exp148|SB202190 10μM R03 exp148]]|-2.85| |[[:results:exp465|Cannabidiol 13μM R08 exp465]]|-2.69| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-2.39| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.35| |[[:results:exp71|KU-0063794 3.8μM R02 exp71]]|-2.19| |[[:results:exp235|Geldanamycin 0.01μM R05 exp235]]|-2.05| |[[:results:exp496|Lead acetate 990μM R08 exp496]]|-1.96| |[[:results:exp433|LJH685 50μM R08 exp433]]|-1.94| |[[:results:exp144|PFI-3 10μM R03 exp144]]|-1.92| |[[:results:exp477|DKK1 89ng/ml R08 exp477]]|-1.84| |[[:results:exp298|Sucrose 20000μM R06 exp298]]|-1.81| |[[:results:exp237|NN-Diethyl-meta-toluamide 100μM R05 exp237]]|-1.8| |[[:results:exp249|Vinorelbine 0.001μM R05 exp249]]|-1.78| |[[:results:exp281|Disulfiram 4.3μM R06 exp281]]|-1.74| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.71| |[[:results:exp295|Pyronaridine 1μM R06 exp295]]|-1.7| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.72| |[[:results:exp532|TIC10 10μM R08 exp532]]|1.75| |[[:results:exp451|Atovaquone 15μM R08 exp451]]|1.77| |[[:results:exp480|ETC-159 50μM R08 exp480]]|1.83| |[[:results:exp469|CFI-400945 25μM R08 exp469]]|1.91| |[[:results:exp401|SNS-032 25μM R07 exp401]]|2.18| |[[:results:exp208|Vinblastine 0.015μM R05 exp208]]|2.27| |[[:results:exp259|6-Thio-2-deoxyguanosine 2μM R06 exp259]]|2.41| |[[:results:exp244|SB743921 0.001μM R05 exp244]]|2.44| ^Gene^Correlation^ |[[:human genes:a:alg13|ALG13]]|0.464| |[[:human genes:g:gmppb|GMPPB]]|0.455| |[[:human genes:r:rnmt|RNMT]]|0.448| |[[:human genes:l:lsm11|LSM11]]|0.434| |[[:human genes:d:dpagt1|DPAGT1]]|0.433| |[[:human genes:g:gfpt1|GFPT1]]|0.429| |[[:human genes:a:alg2|ALG2]]|0.417| |[[:human genes:e:eprs|EPRS]]|0.403| |[[:human genes:d:ddx55|DDX55]]|0.401| |[[:human genes:c:c21orf59|C21orf59]]|0.4| Global Fraction of Cell Lines Where Essential: 719/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|27/28| |blood|27/28| |bone|25/26| |breast|33/33| |central nervous system|55/56| |cervix|4/4| |colorectal|17/17| |esophagus|13/13| |fibroblast|1/1| |gastric|16/16| |kidney|21/21| |liver|20/20| |lung|75/75| |lymphocyte|16/16| |ovary|26/26| |pancreas|24/24| |peripheral nervous system|15/16| |plasma cell|14/15| |prostate|1/1| |skin|23/24| |soft tissue|8/9| |thyroid|2/2| |upper aerodigestive|20/22| |urinary tract|27/29| |uterus|5/5| == Essentiality in NALM6 == * **Essentiality Rank**: 443 * **Expression level (log2 read counts)**: 7.96 {{:chemogenomics:nalm6 dist.png?nolink |}}